| abstract |
The present application relates to novel substituted N-phenethyltriazoloneacetamides, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or for prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, more particularly for treatment and/or prevention of cardiovascular disorders. |